PubMed for id: 459237

Year	Number of Results
1990	2
1995	1
1999	1
2000	1
2002	1
2003	2
2004	5
2005	3
2006	3
2007	5
2008	7
2009	4
2010	7
2011	14
2012	7
2013	12
2014	11
2015	9
2016	10
2017	12
2018	16
2019	21
2020	21
2021	2
2024	0

1

Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways.

Cho JH, Kim K, Kim SA, Park S, Park BO, Kim JH, Kim SY, Kwon MJ, Han MH, Lee SB, Park BC, Park SG, Kim JH, Kim S. Cho JH, et al. Cell Death Differ. 2021 Mar;28(3):900-914. doi: 10.1038/s41418-020-00649-z. Epub 2020 Oct 27. Cell Death Differ. 2021. PMID: 33110214 Free PMC article.

2

Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission.

Shi L, Liu J, Peng Y, Zhang J, Dai X, Zhang S, Wang Y, Liu J, Long J. Shi L, et al. Mol Oncol. 2020 Dec;14(12):3169-3183. doi: 10.1002/1878-0261.12825. Epub 2020 Nov 6. Mol Oncol. 2020. PMID: 33070427 Free PMC article.

3

ALG13 participates in epileptogenesis via regulation of GABA_A receptors in mouse models.

Huo J, Ren S, Gao P, Wan D, Rong S, Li X, Liu S, Xu S, Sun K, Guo B, Wang P, Yu B, Wu J, Wang F, Sun T. Huo J, et al. Cell Death Discov. 2020 Sep 17;6(1):87. doi: 10.1038/s41420-020-00319-6. eCollection 2020. Cell Death Discov. 2020. PMID: 33014431 Free PMC article.

4

OTUD5 promotes innate antiviral and antitumor immunity through deubiquitinating and stabilizing STING.

Guo Y, Jiang F, Kong L, Wu H, Zhang H, Chen X, Zhao J, Cai B, Li Y, Ma C, Yi F, Zhang L, Liu B, Zheng Y, Zhang L, Gao C. Guo Y, et al. Cell Mol Immunol. 2021 Aug;18(8):1945-1955. doi: 10.1038/s41423-020-00531-5. Epub 2020 Sep 2. Cell Mol Immunol. 2021. PMID: 32879469 Free PMC article.

5

OTUB2 Promotes Homologous Recombination Repair Through Stimulating Rad51 Expression in Endometrial Cancer.

Wan Q, Chen Q, Cai D, Zhao Y, Wu X. Wan Q, et al. Cell Transplant. 2020 Jan-Dec;29:963689720931433. doi: 10.1177/0963689720931433. Cell Transplant. 2020. PMID: 32830515 Free PMC article.

6

OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity.

Li F, Sun Q, Liu K, Zhang L, Lin N, You K, Liu M, Kon N, Tian F, Mao Z, Li T, Tong T, Qin J, Gu W, Li D, Zhao W. Li F, et al. Nat Commun. 2020 Aug 21;11(1):4184. doi: 10.1038/s41467-020-17926-7. Nat Commun. 2020. PMID: 32826889 Free PMC article.

7

miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer.

Geng W, Song H, Zhao Q, Dong K, Pu Q, Gao H, Lv Y. Geng W, et al. Biomed Res Int. 2020 May 9;2020:9512793. doi: 10.1155/2020/9512793. eCollection 2020. Biomed Res Int. 2020. PMID: 32775453 Free PMC article.

8

Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions.

Ng BG, Eklund EA, Shiryaev SA, Dong YY, Abbott MA, Asteggiano C, Bamshad MJ, Barr E, Bernstein JA, Chelakkadan S, Christodoulou J, Chung WK, Ciliberto MA, Cousin J, Gardiner F, Ghosh S, Graf WD, Grunewald S, Hammond K, Hauser NS, Hoganson GE, Houck KM, Kohler JN, Morava E, Larson AA, Liu P, Madathil S, McCormack C, Meeks NJL, Miller R, Monaghan KG, Nickerson DA, Palculict TB, Papazoglu GM, Pletcher BA, Scheffer IE, Schenone AB, Schnur RE, Si Y, Rowe LJ, Serrano Russi AH, Russo RS, Thabet F, Tuite A, Villanueva MM, Wang RY, Webster RI, Wilson D, Zalan A; Undiagnosed Diseases Network, University of Washington Center for Mendelian Genomics (UW-CMG); Wolfe LA, Rosenfeld JA, Rhodes L, Freeze HH. Ng BG, et al. J Inherit Metab Dis. 2020 Nov;43(6):1333-1348. doi: 10.1002/jimd.12290. Epub 2020 Aug 5. J Inherit Metab Dis. 2020. PMID: 32681751 Free PMC article.

9

Acetylation-Dependent Deubiquitinase OTUD3 Controls MAVS Activation in Innate Antiviral Immunity.

Zhang Z, Fang X, Wu X, Ling L, Chu F, Li J, Wang S, Zang J, Zhang B, Ye S, Zhang L, Yang B, Lin S, Huang H, Wang A, Zhou F. Zhang Z, et al. Mol Cell. 2020 Jul 16;79(2):304-319.e7. doi: 10.1016/j.molcel.2020.06.020. Mol Cell. 2020. PMID: 32679077 Free article.

10

Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells.

Pu Q, Lv YR, Dong K, Geng WW, Gao HD. Pu Q, et al. BMC Cancer. 2020 Jun 22;20(1):583. doi: 10.1186/s12885-020-07069-9. BMC Cancer. 2020. PMID: 32571254 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

162 results

Results by year